Alzheimer's disease and its treatment by different approaches: A review

S Srivastava, R Ahmad, SK Khare - European Journal of Medicinal …, 2021 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …

Recent applications of PLGA based nanostructures in drug delivery

M Mir, N Ahmed, A ur Rehman - Colloids and Surfaces B: Biointerfaces, 2017 - Elsevier
Over the years, issues associated with non-biodegradable polymers have paved the way for
biodegradable polymers in the domain of pharmaceutical and biomedical sciences. Poly …

Tau-targeted multifunctional nanocomposite for combinational therapy of Alzheimer's disease

Q Chen, Y Du, K Zhang, Z Liang, J Li, H Yu, R Ren… - ACS …, 2018 - ACS Publications
Alzheimer's disease (AD) remains an incurable disease and lacks efficient diagnostic
methods. Most AD treatments have focused on amyloid-β (Aβ) targeted therapy; however, it …

Liposome delivery systems for the treatment of Alzheimer's disease

C Ross, M Taylor, N Fullwood… - International journal of …, 2018 - Taylor & Francis
Alzheimer's disease (AD) will affect around 115 million people worldwide by the year 2050.
It is associated with the accumulation of misfolded and aggregated proteins (β-amyloid and …

Rationally designed peptides and peptidomimetics as inhibitors of amyloid-β (Aβ) aggregation: Potential therapeutics of Alzheimer's disease

D Goyal, S Shuaib, S Mann, B Goyal - ACS combinatorial science, 2017 - ACS Publications
Alzheimer's disease (AD) is a progressive neurodegenerative disease with no clinically
accepted treatment to cure or halt its progression. The worldwide effort to develop peptide …

Applications of various types of nanomaterials for the treatment of neurological disorders

A Waris, A Ali, AU Khan, M Asim, D Zamel, K Fatima… - Nanomaterials, 2022 - mdpi.com
Neurological disorders (NDs) are recognized as one of the major health concerns globally.
According to the World Health Organization (WHO), neurological disorders are one of the …

[图书][B] Metals in medicine

JC Dabrowiak - 2017 - books.google.com
Working from basic chemical principles, Metals in Medicine, 2nd Edition describes a wide
range of metal-based agents for treating and diagnosing disease. Thoroughly revised and …

Recent advancements of nanomedicine in neurodegenerative disorders theranostics

S Mukherjee, VS Madamsetty… - Advanced Functional …, 2020 - Wiley Online Library
Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …

PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier

C Fornaguera, A Dols-Pérez, G Calderó… - Journal of Controlled …, 2015 - Elsevier
Neurodegenerative diseases have an increased prevalence and incidence nowadays,
mainly due to aging of the population. In addition, current treatments lack efficacy, mostly …

Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery

M Nasr - Drug delivery, 2016 - Taylor & Francis
The development of mucoadhesive lipidic nanoemulsion based on hyaluronic acid, co-
encapsulating two polyphenols (resveratrol and curcumin) for the transnasal treatment of …